TGF-β signaling in cancer metastasis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
The transforming growth factor (TGF)-β signaling events are well known to control diverse processes and numerous responses, such as cell proliferation, differentiation, apoptosis, and migration. TGF-β signaling plays context-dependent roles in cancer: in pre-malignant cells TGF-β primarily functions as a tumor suppressor, while in the later stages of cancer TGF-β signaling promotes invasion and metastasis. Recent studies have also suggested that the cross-talk between TGF-β signaling and other signaling pathways, such as Hippo, Wnt, EGFR/RAS, and PI3K/AKT pathways, may substantially contribute to our current understanding of TGF-β signaling and cancer. As a result of the wide-ranging effects of TGF-β, blockade of TGF-β and its downstream signaling components provides multiple therapeutic opportunities. Therefore, the outlook for anti-TGF-β signaling therapy for numerous diseases appears bright and will provide valuable information and thinking on the drug molecular design. In this review, we focus on recent insights into the regulation of TGF-β signaling in cancer metastasis which may contribute to the development of novel cancer-targeting therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, cancer cells adapt to the protective TGF‐β signaling and utilize its moonlighting functions to create a conducive TME by activating CAFs, promoting angiogenesis and ECM production, and suppressing anti‐tumor immune responses [160, 161, 162].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [162]
Citations
Cites
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654 · cited 1×
“LncRNAs can regulate many important cancer-associated phenotypes, including proliferation, apoptosis, or cell migration, through their interactions with DNA, chromatin, signaling and regulatory proteins, and a variety of cellular RNA species [74,75].”
BackgroundSmad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218 · cited 1×
“The HOX-associated lncRNA HOTAIR can reprogram the chromatin landscape genomewide via recruitment of polycomb repressive complex 2 (PRC2), leading to increased breast cancer invasiveness and metastasis [87].”
BackgroundTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101 · cited 1×
“Certain tumors produce metastasis to specific organs independent of vascular anatomy, rate of blood flow, and the number of tumor cells delivered to each organ, and this organotropic metastasis depends on the extracellular vesicles such as exosomal integrins α6β4 and α6β1 [62].”
BackgroundEvolution and Functions of Long Noncoding RNAs
Ponting, C. P., Oliver, P. L., & Reik, W. (2009) · Cell · doi:10.1016/j.cell.2009.02.006 · Cited by 4,208 · cited 1×
“LncRNAs can regulate many important cancer-associated phenotypes, including proliferation, apoptosis, or cell migration, through their interactions with DNA, chromatin, signaling and regulatory proteins, and a variety of cellular RNA species [74,75].”
BackgroundTumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863 · cited 1×
“The miR-200 family has been identified to repress EMT and tumor invasion by targeting the 3′ UTRs of the zinc-finger E-box binding factors 1 and 2 (ZEB1/2) [84,85].”
BackgroundMassagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Long non-coding RNAs: new players in cell differentiation and development
Fatica, A., & Bozzoni, I. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3606 · Cited by 2,980 · cited 1×
“LncRNA BRAF (V600E) regulates melanoma cell migration and lncRNA GAPLINC regulates CD44dependent cell invasiveness [78,79].”
Background
Cited by
Targeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262
TGF‐β signaling: A recap of SMAD‐independent and SMAD‐dependent pathways
Aashaq, S., Batool, A., Mir, S. A., Beigh, M. A., Andrabi, K. I., & Shah, Z. A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30529 · Cited by 211
The roles of exosomal miRNAs and lncRNAs in lung diseases
Li, Y., Yin, Z., Fan, J., Zhang, S., & Yang, W. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0080-7 · Cited by 190
Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
Parichatikanond, W., Luangmonkong, T., Mangmool, S., & Kurose, H. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00034 · Cited by 175
“The tumor promoting effects of TGF-β such as EMT, invasion, metastasis, and angiogenesis emerge when cancer progresses to a later stage (5, 87).”
BackgroundCytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Adekoya, T. O., & Richardson, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124449 · Cited by 170
“Similarly in bone metastasis, there is enhanced activation of TGFβ signaling [173].”
BackgroundKciuk, M., Gielecińska, A., Budzinska, A., Mojzych, M., & Kontek, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073847 · Cited by 164
The role of ubiquitin-specific peptidases in cancer progression
Young, M.-J., Hsu, K.-C., Lin, T. E., Chang, W.-C., & Hung, J.-J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0522-0 · Cited by 164
Wang, M., Zhai, X., Li, J., Guan, J., Xu, S., Li, Y., & Zhu, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670391 · Cited by 162
Advances in PSMA-targeted therapy for prostate cancer
Wang, F., Li, Z., Feng, X., Yang, D., & Lin, M. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00394-5 · Cited by 156
Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
Bai, X., Yi, M., Jiao, Y., Chu, Q., & Wu, K. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s224013 · Cited by 153
Non-coding RNA in bladder cancer
Li, Y., Li, G., Guo, X., Yao, H., Wang, G., & Li, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.023 · Cited by 138
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
Ouyang, P., Wang, L., Wu, J., Tian, Y., Chen, C., Li, D., Yao, Z., Chen, R., Xiang, G., Gong, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1344272 · Cited by 137
Cancer metastasis as a non-healing wound
Deyell, M., Garris, C. S., & Laughney, A. M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01309-w · Cited by 113
Zhang, Z., Zhang, X., Zhao, D., Liu, B., Wang, B., Yu, W., Li, J., Yu, X., Cao, F., Zheng, G., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10051 · Cited by 101
TGF‐β1 activates RSC96 Schwann cells migration and invasion through MMP‐2 and MMP‐9 activities
Muscella, A., Vetrugno, C., Cossa, L. G., & Marsigliante, S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14913 · Cited by 96
Shen, X., Hu, X., Mao, J., Wu, Y., Liu, H., Shen, J., Yu, J., & Chen, W. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2254-1 · Cited by 95
Remodelling of the tumour microenvironment by the kallikrein-related peptidases
Srinivasan, S., Kryza, T., Batra, J., & Clements, J. A. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00436-z · Cited by 95
Li, X.-S., Wu, Y., & Tian, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214436 · Cited by 95
Contextual Regulation of TGF-β Signaling in Liver Cancer
Tu, S., Huang, W., Huang, C., Luo, Z., & Yan, X. (2019) · Cells · doi:10.3390/cells8101235 · Cited by 81
SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases
Trehan, R., Huang, P., Zhu, X. B., Wang, X., Soliman, M., Strepay, D., Nur, A., Kedei, N., Arhin, M., Ghabra, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59529-0 · Cited by 74
Fattah, Y. K. A. E., Abulsoud, A. I., AbdelHamid, S. G., & Hamdy, N. Μ. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.209 · Cited by 73
Tune, B. X. J., Sim, M. S., Poh, C. L., Guad, R. M., Choy, K. W., Hazarika, I., Das, A., Gopinath, S. C. B., Rajan, M., Sekar, M., et al. (2022) · Journal of Oncology · doi:10.1155/2022/3249766 · Cited by 72
“One example is that MMP-9 enhances TGF-β activity, which promotes cancer invasion in metastatic cancers [52, 74].”
BackgroundBreast cancer stem cells: A review of their characteristics and the agents that affect them
Shan, N. L., Shin, Y. S., Yang, G., Furmanski, P., & Suh, N. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23277 · Cited by 71
The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches
Zafari, N., Khosravi, F., Rezaee, Z., Esfandyari, S., Bahiraei, M., Bahramy, A., Ferns, G. A., & Avan, A. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24585 · Cited by 69
Zhang, Y., Qian, L., Li, N., Xu, M. Q., Miyamoto, T., & Liu, J. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00402-4 · Cited by 66
Ming, J. X., Wang, Z. C., Huang, Y., Ohishi, H., Wu, R. J., Shao, Y. X., Wang, H., Qin, M., Wu, Z., Li, Y. Y., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113302 · Cited by 65
Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment
Stuelten, C. H., & Zhang, Y. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764727 · Cited by 62
MiRNA-related metastasis in oral cancer: moving and shaking
Eslami, M., Khazeni, S., Khanaghah, X. M., Asadi, M. H., Ansari, M. A., Garjan, J. H., Lotfalizadeh, M. H., Bayat, M., Taghizadieh, M., Taghavi, S. P., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03022-5 · Cited by 60
Zhu, J., Li, B., Xu, M., Liu, R., Xia, T., Zhang, Z., Xu, Y., & Liu, S. (2019) · ACS Nano · doi:10.1021/acsnano.9b07891 · Cited by 60
Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
Jian, Y., Yang, K., Sun, X., Zhao, J. J., Huang, K., Al-Danakh, A., Xu, Z., Wu, H., Xu, Q., Zhang, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639636 · Cited by 60
“Although TGF-β has a tumor suppressive effect by inhibiting cell cycle progression and promoting early cancer cell apoptosis, it promotes tumor development, metastases, and inhibits host anti-tumor immunity in advanced stages via encouraging transformation from epithelial cells to stromal cells, and by encouraging imm…”
BackgroundSelf-citationOxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links?
D’Souza, L. C., Mishra, S., Chakraborty, A., Shekher, A., Sharma, A., & Gupta, S. C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7987 · Cited by 59
“During the transition, TGF signaling enhances the expression of mesenchymal markers such as N-cadherin and vimentin and attenuates the epithelial markers such as E-cadherin (150).”
A Novel Synthetic Toehold Switch for MicroRNA Detection in Mammalian Cells
Wang, S., Emery, N. J., & Liu, A. P. (2019) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00530 · Cited by 59
Burdak‐Rothkamm, S., & Rothkamm, K. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.08.001 · Cited by 58
Wu, S., Wang, Y., Yuan, Z., Wang, S., Du, H., Liu, X., Wang, Q., & Zhu, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9664 · Cited by 55
The role of clonal communication and heterogeneity in breast cancer
Martín-Pardillos, A., Valls‐Chiva, A., Vargas, G. B., Hurtado, P., Piñeiro, R., Guijarro-Carrillo, P. J., Hümmer, S., Serrano, E., Rodríguez‐Casanova, A., Díaz‐Lagares, Á., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5883-y · Cited by 56
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
Fendl, B., Berghoff, A. S., Preusser, M., & Maier, B. (2023) · ESMO Open · doi:10.1016/j.esmoop.2022.100776 · Cited by 54
“Based on this dual role, TGF-b-blocking antibodies were developed which showed efficacy in cancer models.(131,133,134,137) The consequences of TGF-b blocking on macrophages are still understudied, but potentially lead to a reversion of their immunosuppressive phenotype.”
BackgroundYang, Y., Liu, L., Fang, M., Bai, H., & Xu, Y. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.03.002 · Cited by 53
Molecular mediators of breast cancer metastasis
Yeeravalli, R., & Das, A. (2021) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2021.02.002 · Cited by 53
Imodoye, S. O., Adedokun, K. A., Muhammed, A. O., Bello, I. O., Muhibi, M. A., Oduola, T., & Oyenike, M. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762817 · Cited by 53
Therapeutic targeting of TGF ‐β in lung cancer
Aftabi, S., Behrooz, A. B., Cordani, M., Rahiman, N., Sadeghdoust, M., Aligolighasemabadi, F., Pistorius, S., Alavizadeh, S. H., Taefehshokr, N., & Ghavami, S. (2024) · FEBS Journal · doi:10.1111/febs.17234 · Cited by 52
“This involves recruiting like phosphatidylinositol 3 kinase (PI3K) – AKT – TOR pathway, various mitogen-activated protein kinase (MAPK) cascades (ERK, JNK, and p38 MAPKs), and pathway downstream of Rho-like GTPase signaling intermediates [31,33,36].”
Hsiao, Y., Chi, J.-Y., Li, C., Chen, L., Chen, Y., Liang, H., Lo, Y.-C., Hong, J., Chuu, C., Hung, L., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.724 · Cited by 52
Hsueh, C., Huang, Q., Gong, H., Shen, Y., Sun, J., Lau, H., Zhang, D., Tang, D., Wu, C., Guo, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103829 · Cited by 50
“Multiple studies have suggested the existence of direct or indirect cross talk between TGF-b signaling and PI3K/AKT signaling (Gu and Feng, 2018; Xie et al., 2018).”
BackgroundNovel Methylation Biomarkers for Colorectal Cancer Prognosis
Gutierrez, A. R., Demond, H., Brebi, P., & Ili, C. (2021) · Biomolecules · doi:10.3390/biom11111722 · Cited by 50
“Aberrant activation of TGF-β results in cell-cycle modifications [35] and is involved in immune suppression, growth inhibition, epithelial-to-mesenchymal transition (EMT), and cell migration, among others [34].”
BackgroundDash, S., Sahu, A. K., Srivastava, A., Chowdhury, R., & Mukherjee, S. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155348 · Cited by 49
Jumonji domain‐containing protein 6 protein and its role in cancer
Yang, J., Chen, S., Yang, Y., Ma, X., Shao, B., Yang, S., Wei, Y., & Wei, X. (2020) · Cell Proliferation · doi:10.1111/cpr.12747 · Cited by 48
Huang, J., Zhang, L., Zhou, W., Wang, J., Zhang, R., Wang, Z., Ran, H., Li, P., & Li, R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120856 · Cited by 48
Self-citationNazio, F., Pò, A., Abballe, L., Ballabio, C., Diomedi‐Camassei, F., Bordi, M., Camera, A., Caruso, S., Caruana, I., Pezzullo, M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02347-7 · Cited by 48
“While previous reports have associated the TGF-β pathway with pro-migratory potential of MB [101], a strict correlation between stemness and motility has been found to be crucial for MBGroup3 dissemination capability [28, 33, 46].”
BackgroundChen, Y., Wang, B., Chen, Y., Wu, Q., Lai, W., Wei, L., Nandakumar, K. S., & Liu, D. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888612 · Cited by 46
“Besides limited cell migration in pre-malignant cells (28), it cross-talks with multiple inflammation pathways (29).”
BackgroundWei, L., Zhang, X., Wang, J., Ye, Q., Zheng, X., Qiu, P., Zheng, Y., Liu, P., Zhang, X., Li, Z., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0970-8 · Cited by 42
Grote, S., Ureña-Bailén, G., Chan, K. C.-H., Baden, C., Mezger, M., Handgretinger, R., & Schleicher, S. (2021) · Cells · doi:10.3390/cells10051020 · Cited by 41
“Soluble factors such as TGFβ, which are highly secreted within the TME, have been shown to facilitate metastatic development as well as tumor escape mechanisms during treatment with primary immune cells [44,45].”
BackgroundChromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 Axis
Wang, L., Wang, E., Balcazar, J. P., Wu, Z., Xiang, K., Wang, Y., Huang, Q., Negrete, M., Chen, K., Li, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202004673 · Cited by 41
Self-citationHan, Y., Luo, D., Kaken, H., Julaiti, T., Zhao, W., Wang, W., Aikebaier, W., & Wang, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.813809 · Cited by 40
Ullah, A., Jiao, W., & Shen, B. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00591-9 · Cited by 40
E-cadherin on epithelial–mesenchymal transition in thyroid cancer
Zhu, X., Wang, X., Gong, Y., & Deng, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02344-6 · Cited by 39
“TGF‐β involved in the regulation of E‐cadherin In tumors, TGF-β functions are complex and diverse due to different backgrounds and stages of tumors, not only acting as a suppressor to inhibit the occurrence and development of tumor cells in the early stage, but also to inhibit the invasion and metastasis in the late s…”
BackgroundTumor associated neutrophils promote the metastasis of pancreatic ductal adenocarcinoma
Lianyuan, T., Gang, L., Tao, M., Dianrong, X., Chunhui, Y., Ma, Z., & Jiang, B. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1807250 · Cited by 38
LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
Zhong, C., Xie, Z., Shen, J., Jia, Y., & Duan, S. (2022) · Cells · doi:10.3390/cells11091540 · Cited by 37
“In late stages of ca cer, TGF-β sig aling increases the expression of mesenchymal markers Cells 2022, 11, 1540 12 of 21 N-cadherin and vimentin and downregulates the epithelial marker E-cadherin to promote EMT in tumor cells by mediating SMAD [47].”
BackgroundAhuja, S., & Zaheer, S. (2023) · Cell Biology International · doi:10.1002/cbin.12097 · Cited by 37
“There are various other transcription factors through which Smad proteins can be directed to particular specific areas of genes (David & Massagué, 2018; Massagué, 2012). stabilize/enhance their DNA binding thus controlling the response of Smad complex (Hill, 2016).”
BackgroundInfluentialThe Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers
Matsuoka, T., & Yashiro, M. (2023) · Biomolecules · doi:10.3390/biom13101551 · Cited by 36
Yang, J.-F., Shi, S.-N., Xu, W., Qiu, Y., Zheng, J., Yu, K., Song, X., Li, F., Wang, Y., Wang, R., et al. (2019) · Aging · doi:10.18632/aging.102540 · Cited by 36
Zheng, X., Sun, R., & Wei, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1438235 · Cited by 36
Transition metals in angiogenesis – A narrative review
Dürig, J., Calcagni, M., & Buschmann, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100757 · Cited by 35
Deswal, B., Bagchi, U., & Kapoor, S. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206275259231105184959 · Cited by 34
Zhu, C., Huang, L., Xu, F., Li, P., Li, P., & Hu, F. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.136 · Cited by 33
Tuffour, A., Kosiba, A. A., Zhang, Y., Addai, F. P., Gu, J., & Shi, H. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188528 · Cited by 33
USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1
Song, C., Peng, J., Wei, Y., Shao, J., Chen, X., Zhang, X., & Xu, J. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112884 · Cited by 33
Soghli, N., Ferns, G. A., Sadeghsoltani, F., Qujeq, D., Yousefi, T., & Vaghari‐Tabari, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115094 · Cited by 32
TGF-β in tumor development and progression: mechanisms and therapeutics
Liu, J., Wang, Y., Tang, C., Zhang, L., Xiong, S., Wang, J., & Dong, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00403-w · Cited by 31
“In normal cells and tissues, activated TGF-β signaling mainly functions as a G1-S cell-cycle check-point to regulate the survival, proliferation, and genome integrity of cells, thereby effectively restricting the malignant transformation [1, 2].”
Self-citationZhou, L., Zhang, Z., Huang, Z., Nice, E. C., Zou, B., & Huang, C. (2020) · Molecular Biomedicine · doi:10.1186/s43556-020-00004-1 · Cited by 31
PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT
Xiao, J., Zhou, N., Li, Y., Xiao, Y., Chen, W., Ye, J., Ma, T., & Zhang, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110743 · Cited by 31
Yang, M. H., Baek, S. H., Chinnathambi, A., Alharbi, S. A., & Ahn, K. S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6938 · Cited by 31
miR-1269a and miR-1269b: Emerging Carcinogenic Genes of the miR-1269 Family
Xie, Z., Zhong, C., & Duan, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.809132 · Cited by 31
“In colorectal cancer, TGF-β can activate miR-1269a by promoting Sox4, inhibit SMAD7 and HOXD10, thereby enhancing TGF-β signaling and forming a positive feedback loop, promoting the EMT and metastasis of tumor cells (Bu et al., 2015) (Figure 2). miR-1269a and the p53 Signaling Pathway p53 is an important tumor suppres…”
BackgroundInfluentialNegative regulation of TGF-β by AMPK and implications in the treatment of associated disorders
Gao, J., Ye, J., Ying, Y., Lin, H., & Luo, Z. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy028 · Cited by 31
Lee, Y.-J., Park, J., & Oh, S. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.015 · Cited by 31
Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma
Gu, H.-Y., Zhang, C., Guo, J., Yang, M., Zhong, H.-C., Jin, W., Liu, Y., Gao, L., & Wei, R. (2020) · Aging · doi:10.18632/aging.102847 · Cited by 30
Lin, R., Li, X., Wu, S., Qian, S., Hou, H., Dong, M., Zhang, X., & Zhang, M. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112790 · Cited by 30
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Qin, L., & Wu, J. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116751 · Cited by 30
Molecular Landscape of the Epithelial–Mesenchymal Transition in Endometrioid Endometrial Cancer
Opławski, M., Nowakowski, R., Średnicka, A., Ochnik, D., Grabarek, B. O., & Boroń, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071520 · Cited by 28
“Currently, it is evident, however, that in neoplastically changed cells, TGFβ plays the role of a tumor progression promoter as well as the formation of distant metastatic foci [34].”
BackgroundResultHan, Y., Wang, X., Xia, K., & Su, T. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4990 · Cited by 28
Modulation of cancer cell signaling by long noncoding RNAs
Mirhosseini, S. A., Sarfi, M., Tehrani, S. S., Mirazakhani, M., Maniati, M., & Amani, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28847 · Cited by 26
“TGF‐β is a cytokine that plays an important role in the cellular and molecular process associated with apoptosis, differentiation, extracellular matrix (ECM) production and motility.(15) The molecular mechanism of TGF‐β in cancer cells depends on the progression of cancer.”
BackgroundAcousto-holographic reconstruction of whole-cell stiffness maps
Varol, R., Karavelioğlu, Z., Omeroglu, S., Aydemir, G., Karadag, A., Meco, H. E., Demirçalı, A. A., Yılmaz, A., Calibasi‐Kocal, G., Gençoğlan, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35075-x · Cited by 26
IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer
Deng, Y., Yang, X., Hua, H., & Zhang, C. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s370576 · Cited by 25
Júnior, R. F. D. A., Lira, G. A., Schomann, T., Cavalcante, R. S., Vilar, N. F., de Paula, R. C. M., Gomes, R. F., Chung, C. K., Jorquera‐Cordero, C., Vepris, O., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101647 · Cited by 25
Rossi, F. A., Steinberg, J. H. E., Calvo-Roitberg, E., Joshi, M., Pandey, A., Abba, M. C., Dufrusine, B., Buglioni, S., Laurenzi, V. D., Sala, G., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00318-x · Cited by 25
Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer
Liu, Y., Wang, C., Li, J., Zhu, J., Zhao, C., & Xu, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633453 · Cited by 25
“Among animal models, the TGF-β family significantly impacts metabolism and plays a critical role in tumor transformation, proliferation, invasion, extracellular matrix (ECM) production, and immune reaction (Xie et al., 2018).”
BackgroundRahman, Z., Bordoloi, A., Rouhana, H., Tavasso, M., van der Zon, G., Garbin, V., ten Dijke, P., & Boukany, P. E. (2024) · Lab on a Chip · doi:10.1039/d3lc00886j · Cited by 23
Bioinformatic analysis reveals hub genes and pathways that promote melanoma metastasis
Su, W., Guan, Y., Huang, B., Wang, J., Wei, Y., Zhao, Y., Jiao, Q., Ji, J., Yu, D., Xu, L., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07372-5 · Cited by 23
Susanto, H., Firdaus, S. R. A., Sholeh, M., Endharti, A. T., Taufiq, A., Malek, N. A. N. N., & Permatasari, H. K. (2024) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2024.101149 · Cited by 22
Pal, A., Ashworth, J. C., Collier, P., Probert, C., Jones, S. J., Leza, E. P., Meakin, M. L., Ritchie, A., Onion, D., Clarke, P. A., et al. (2020) · Cancers · doi:10.3390/cancers12082290 · Cited by 22
“To study the mechanism of induced proliferation and invasion by MSCs in BCCs, we focus our attention on the crosstalk between TGFβ and Wnt signalling as known effectors of the tumour Cancers 2020, 12, 2290 7 of 16 microenvironment on BCC behaviour and inducers of EMT [43].”
BackgroundInfluentialTGFβ Signaling in the Tumor Microenvironment
Goulet, C. R., & Pouliot, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_6 · Cited by 22
Dong, H. F., Zhang, Y., Xu, Y. H., Ma, R., Liu, L., Luo, C., & Jiang, W. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz046 · Cited by 22
RETRACTED: Role of AP-2α/TGF-β1/Smad3 axis in rats with intervertebral disc degeneration
Li, H., Li, W., Liang, B., Wei, J., Yin, D., & Fan, Q. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118567 · Cited by 21
RetractedKang, E., Kim, K., Jeon, S. Y., Jung, J. G., Kim, H. K., Lee, H.-B., & Han, W. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-021-00419-0 · Cited by 21
“However, in breast cancer, the metastasispromoting function of the TGF-β signaling is potentiated via multiple mechanisms [47, 48], and indeed the high expression of cytoplasmic TGF-β in the TNBC tumors is associated with greater metastatic burden and worse prognosis [49].”
BackgroundMarguier, A., Laheurte, C., Lecoester, B., Malfroy, M., Boullerot, L., Renaudin, A., Seffar, E., Kumar, A., Nardin, C., Aubin, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932298 · Cited by 21
Cerveró-Varona, A., Canciello, A., Peserico, A., Haidar-Montes, A. A., Citeroni, M. R., Mauro, A., Russo, V., Moffa, S., Pilato, S., Giacomo, S. D., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100758 · Cited by 21
“The intracellular signaling is activated by TGFβR complex’s receptor and operates on SMADs (SMAD2/3) effectors by inducing the serine phosphorylation upon ligand binding [58].”
BackgroundMLL1 regulates cytokine-driven cell migration and metastasis
Nair, P. R., Danilova, L., Gómez‐de‐Mariscal, E., Kim, D., Fan, R., Muñoz‐Barrutia, A., Fertig, E. J., & Wirtz, D. (2024) · Science Advances · doi:10.1126/sciadv.adk0785 · Cited by 21
Babu, V. D., Anandasadagopan, S. K., & Sudhandiran, G. (2020) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1814803 · Cited by 21
Manickam, N., Radhakrishnan, R. K., Andrews, J. F. V., Selvaraj, D. B., & Kandasamy, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118569 · Cited by 21
Li, Y., Chen, C., Chang, C., Chiang, J. Y., Chu, C., Chen, H., & Yip, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62280 · Cited by 21
Metadata
- Authors
- Xie, F., Ling, L., Van Dam, H., Zhou, F., & Zhang, L.
- Affiliations
- Soochow University (CN)
- Zhejiang University (CN)
- Venue
- Acta Biochimica et Biophysica Sinica
- Published
- 2018-01-01
- Volume
- 50
- Issue
- 1
- Pages
- 121-132
- ISSN
- 1672-9145 (ISSN-L)
- OpenAlex
- W2770010368
- Cited by
- 231
- References
- 125
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 29 · 2023: 32 · 2022: 46 · 2021: 40 · 2020: 32 · 2019: 20 · 2018: 5
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Biochimica et Biophysica Sinica (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- The National Basic Research Program of China (2016YFA0502500)
- National Natural Science Foundation of China (31471315, 31671457, 31571460, 31701232)
- The National Science Foundation for Post-doctoral Scientists of China (BX201700165)
- Zhejiang Natural Science Foundation (R14C070002)
- Jiangsu Natural Science Foundation (BK20150354)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- TGF-beta signaling, metastasis, tumor suppressor function, tumor invasion, signaling crosstalk, Hippo signaling pathway, Wnt signaling, PI3K/Akt signaling, anti-TGF-beta therapy
- MeSH terms
- Antineoplastic Agents, Humans, Models, Biological, Neoplasm Metastasis, Neoplasms, Signal Transduction, Transforming Growth Factor beta, Disease Progression, Tumor Suppressor Proteins, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.